The relative prognostic value of plasma HIV RNA levels and CD4 lymphocyte counts in advanced HIV infection

被引:73
作者
Lepri, AC
Katzenstein, TL
Ullum, H
Phillips, AN
Skinhoj, P
Gerstoft, J
Pedersen, BK
机构
[1] UCL, Royal Free & Univ Coll, Sch Med, Royal Free Ctr HIV Med, London NW3 2PF, England
[2] UCL, Royal Free & Univ Coll, Sch Med, Dept Primary Care & Populat Sci, London NW3 2PF, England
[3] Rigshosp, Rhima Ctr, Dept Infect Dis, DK-2100 Copenhagen, Denmark
关键词
HIV progression; prognostic value; statistical interaction;
D O I
10.1097/00002030-199813000-00011
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Objective: It has been suggested that the plasma HIV RNA level is a better predictor of AIDS and death than the CD4 lymphocyte count. We assessed whether the prognostic value of plasma virus levels was different according to the CD4 count. Design: Prospective cohort study of HIV-infected patients followed for a median of 2.91 years (range, 0.02-4.54). Setting: Department of Infectious Diseases at Rigshospitalet, Copenhagen, Denmark. Participants: A group of 255 HIV-infected individuals with an initial measurement of CD4 lymphocyte count and plasma HIV RNA. Main outcome measure: Survival time. Results: The plasma HIV RNA (median 101 410 copies/ml; range (range 200-7 200 000) and the CD4 lymphocyte count (median 250 cells x 10(6)/l; range 1-1247) were negatively correlated (Pearson r = -0.53; P < 0.00001). Of the 255 patients, 110 died during follow-up. Overall, a higher HIV RNA level was associated with increased risk of death, but the association was smaller in patients with lower CD4 lymphocyte counts (test for interaction P < 0.0001). In patients with CD4 count below 50 cells x 10(6)/l the association between HIV RNA and risk of death was not statistically significant (relative hazard per 10-fold higher HIV RNA level was 1.53; P = 0.11; adjusted for age and CD4 count) while that between the CD4 count and risk of death was highly significant (relative hazard per 50% towel CD4 count 1.38; P = 0.005; adjusted for age and HIV RNA level). Conclusions: Patients were relatively lightly treated with antiretroviral drugs both before and during this study. In this situation, it appears that the HIV RNA level has a relatively weak association with risk of death in patients with advanced HIV infection and that the CD4 lymphocyte count is probably more useful in assessing prognosis. (C) 1998 Lippincott Williams & Wilkins.
引用
收藏
页码:1639 / 1643
页数:5
相关论文
共 33 条
[1]  
CAMERON B, 1996, 3 C RETR OPP INF WAS
[2]   PLASMA VIREMIA IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTION [J].
COOMBS, RW ;
COLLIER, AC ;
ALLAIN, JP ;
NIKORA, B ;
LEUTHER, M ;
GJERSET, GF ;
COREY, L .
NEW ENGLAND JOURNAL OF MEDICINE, 1989, 321 (24) :1626-1631
[3]   AIDS prognosis based on HIV-1 RNA, CD4+ T-cell count and function: Markers with reciprocal predictive value over time after seroconversion [J].
deWolf, F ;
Spijkerman, I ;
Schellekens, PT ;
Langendam, M ;
Kuiken, C ;
Bakker, M ;
Roos, M ;
Coutinho, R ;
Miedema, F ;
Goudsmit, J .
AIDS, 1997, 11 (15) :1799-1806
[4]   Survival with AIDS in Ireland [J].
Dunne, MT ;
Ruskin, HJ ;
Mulcahy, FM .
AIDS, 1997, 11 (10) :1281-1290
[5]   Impact of new antiretroviral combination therapies in HIV infected patients in Switzerland: prospective multicentre study [J].
Egger, M ;
Hirschel, B ;
Francioli, P ;
Sudre, P ;
Wirz, M ;
Flepp, M ;
Rickenbach, M ;
Malinverni, R ;
Vernazza, P ;
Battegay, M ;
Bernasconi, E ;
Burgisser, P ;
Erb, P ;
Fierz, W ;
Grob, P ;
Gruninger, U ;
Jeannerod, L ;
Ledergerber, B ;
Luthy, R ;
Matter, L ;
Opravil, M ;
Paccaud, F ;
Perrin, L ;
Pichler, W ;
Piffaretti, GC ;
Rutschmann, O ;
Zanetti, G .
BMJ-BRITISH MEDICAL JOURNAL, 1997, 315 (7117) :1194-1199
[6]   QUANTITATION OF HIV VIRAL BURDEN BY PCR IN HIV SEROPOSITIVE NAVY PERSONNEL REPRESENTING WALTER REED STAGES 1 TO 6 [J].
FERRE, F ;
MARCHESE, A ;
DUFFY, PC ;
LEWIS, DE ;
WALLACE, MR ;
BEECHAM, HJ ;
BURNETT, KG ;
JENSEN, FC ;
CARLO, DJ .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1992, 8 (02) :269-275
[7]   Prognostic value of viremia in patients with long-standing human immunodeficiency virus infection [J].
GalettoLacour, A ;
Yerly, S ;
Perneger, TV ;
Baumberger, C ;
Hirschel, B ;
Perrin, L ;
Battegay, M ;
Burgisser, P ;
Doorly, R ;
Egger, M ;
Erb, P ;
Fierz, W ;
Flepp, M ;
Francioli, P ;
Grob, P ;
Gruninger, U ;
Ledergerber, B ;
Luthy, R ;
Malinverni, R ;
Matter, L ;
Opravil, M ;
Paccaud, F ;
Pichler, W ;
Rickenbach, M ;
Rutschmann, O ;
Vernazza, P ;
vonOverbeck, J .
JOURNAL OF INFECTIOUS DISEASES, 1996, 173 (06) :1388-1393
[8]  
GREENBERG BL, 1997, 4 C RETR OPP INF WAS
[9]  
Henrard Denis R., 1995, JAMA (Journal of the American Medical Association), V274, P554, DOI 10.1001/jama.274.7.554
[10]   QUANTITATION OF HUMAN IMMUNODEFICIENCY VIRUS TYPE-1 IN THE BLOOD OF INFECTED PERSONS [J].
HO, DD ;
MOUDGIL, T ;
ALAM, M .
NEW ENGLAND JOURNAL OF MEDICINE, 1989, 321 (24) :1621-1625